BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38196063)

  • 1. Antifungal Resistance in Pulmonary Aspergillosis.
    Verweij PE; Song Y; Buil JB; Zhang J; Melchers WJG
    Semin Respir Crit Care Med; 2024 Feb; 45(1):32-40. PubMed ID: 38196063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.
    Denning DW; Park S; Lass-Florl C; Fraczek MG; Kirwan M; Gore R; Smith J; Bueid A; Moore CB; Bowyer P; Perlin DS
    Clin Infect Dis; 2011 May; 52(9):1123-9. PubMed ID: 21467016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
    Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
    Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
    Gamaletsou MN; Denning DW
    Mycopathologia; 2017 Dec; 182(11-12):1125-1129. PubMed ID: 28702854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus fumigatus Strain-Specific Conidia Lung Persistence Causes an Allergic Broncho-Pulmonary Aspergillosis-Like Disease Phenotype.
    Jones JT; Liu KW; Wang X; Kowalski CH; Ross BS; Mills KAM; Kerkaert JD; Hohl TM; Lofgren LA; Stajich JE; Obar JJ; Cramer RA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33597172
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspergillus fumigatus In-Host HOG Pathway Mutation for Cystic Fibrosis Lung Microenvironment Persistence.
    Ross BS; Lofgren LA; Ashare A; Stajich JE; Cramer RA
    mBio; 2021 Aug; 12(4):e0215321. PubMed ID: 34465017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cytokine Changes in a Patient with Chronic Pulmonary Aspergillosis Overlapping with Allergic Bronchopulmonary Aspergillosis.
    Tsukamoto Y; Ito Y; Obase Y; Takazono T; Nakada N; Ashizawa N; Hirayama T; Takeda K; Ide S; Iwanaga N; Tashiro M; Hosogaya N; Fukahori S; Fukushima C; Yanagihara K; Izumikawa K; Mukae H
    Intern Med; 2024 Jun; 63(11):1659-1664. PubMed ID: 37899245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Elphick HE; Southern KW
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002204. PubMed ID: 27820955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Elphick HE; Southern KW
    Cochrane Database Syst Rev; 2014 Nov; (11):CD002204. PubMed ID: 25431975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Elphick HE; Southern KW
    Cochrane Database Syst Rev; 2012 Jun; (6):CD002204. PubMed ID: 22696329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis.
    Moss RB
    Curr Opin Pulm Med; 2010 Nov; 16(6):598-603. PubMed ID: 20720494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of Echinocandin Resistance Due to a Point Mutation in the
    Jiménez-Ortigosa C; Moore C; Denning DW; Perlin DS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of pulmonary aspergillosis.
    Kanj A; Abdallah N; Soubani AO
    Respir Med; 2018 Aug; 141():121-131. PubMed ID: 30053957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Francis NZ; Southern KW
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002204. PubMed ID: 36053129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical spectrum of pulmonary aspergillosis.
    Kosmidis C; Denning DW
    Thorax; 2015 Mar; 70(3):270-7. PubMed ID: 25354514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of pathogenic CFTR variants in Greek cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus fumigatus chronic colonization: A retrospective cohort study.
    Noni M; Katelari A; Poulou M; Ioannidis D; Kapasouri EM; Tzetis M; Doudounakis SE; Kanaka-Gantenbein C; Spoulou V
    J Mycol Med; 2023 Mar; 33(1):101326. PubMed ID: 36272381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
    Denning DW; Cadranel J; Beigelman-Aubry C; Ader F; Chakrabarti A; Blot S; Ullmann AJ; Dimopoulos G; Lange C;
    Eur Respir J; 2016 Jan; 47(1):45-68. PubMed ID: 26699723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Elphick H; Southern K
    Cochrane Database Syst Rev; 2000; (4):CD002204. PubMed ID: 11034746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.